Senegal
Senegal has successfully joined the growing list of Africa countries to secure the patent right to manufacture the Covid’19 vaccines next year.
The West African country signed a deal on Monday with a Belgian biotech group Univercells to produce the jabs from next year.
As the world is rushing to vaccinate billions of people against the pandemic, Africa’s initiative to secure the jabs has been minimal given that only 7 million people have been vaccinated.
Senegal joins the likes of Egypt, Morocco and South Africa in the list of African countries that have successfully secured the rights to produce the jabs.
Several reports revealed that the UNivercells had signed a letter of intent for collaboration with Institut Pasteur in Senegal in April.
Univercell further revealed that it will transfer its line of production to Senegal in mid-2022.
The production process will involve the hiring of locals and once the production is fully effected, the jabs will be distributed in the West African region.
01:15
Ivorians welcome reopening of land borders
00:55
Ivory Coast reopens land borders closed since 2020
Go to video
Togo's Covid-19 fund scandal: Government denies misappropriation claims
Go to video
Togo in Uproar: Mismanagement of Covid-19 funds sparks outrage and calls for accountability
Go to video
Senegalese civil society group files complaint after billions lost to misuse of Covid funds
Go to video
Top 5 economies in Sub-Saharan Africa to watch out for in 2023, according to IMF